Privia Health Group earnings release, August 6, 2026

Privia Health Group, Inc. (PRVA) · Form 8-K, Item 2.02 · Filed · SEC filing

Privia Health Reports Strong Second Quarter and Year-to-Date 2026 Results – 2Q’26 Net Income of $9.0M, +236.7% from 2Q’25 – 2Q’26 Adjusted EBITDA of $37.4M, +29.1% from 2Q’25 – Full-Year 2026 Guidance Raised for All Key Financial Metrics

ARLINGTON, VA – August 6, 2026 – Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial results for the second quarter and six-month periods ended June 30, 2026.

Second Quarter Performance

Key Operating and Non-GAAP Financial Metrics c¹

Six-Month Performance

Key Operating and Non-GAAP Financial Metrics b d e

Updated Full-Year 2026 Guidance d e f g

• Expect approximately 70-80% of Adjusted EBITDA to convert to free cash flow in full-year 2026 subject to timing of MSSP cash settlement

• Guidance does not assume any new business development activity d.

Management has not reconciled forward-looking non-GAAP measures to their most directly comparable GAAP measures of Gross Profit, Operating Income and Net Income. This is because the Company cannot predict with reasonable certainty and without unreasonable efforts the ultimate outcome of certain GAAP components of such reconciliations due to market-related assumptions that are not within our control as well as certain legal or advisory costs, tax costs or other costs that may arise. For these reasons,² management is unable to assess the probable significance of the unavailable information, which could materially impact the amount of the future directly comparable GAAP measures. e.

See “Key Metrics and Non-GAAP Financial Measures” for more information as to how the Company defines and calculates Implemented Providers, Attributed Lives, Practice Collections, Care Margin, Platform Contribution, and Adjusted EBITDA, and for a reconciliation of the most comparable GAAP measures to Care Margin, Platform Contribution, Adjusted EBITDA, Adjusted Net Income and Adjusted Net Income Per Share. f.

Certain non-recurring or non-cash and other expenses will be treated as an add back in the reconciliation of Net Income to Adjusted EBITDA, and the reconciliation of Net Income to Adjusted Net Income and Adjusted Net Income Per Share, the details of which can be found in the Reconciliation schedules near the end of this and in future quarterly press releases. g.

Any slight variations in totals due to rounding.

Webcast and Conference Call Information

The Company will host a conference call on August 6, 2026, at 8:00 am ET to discuss these results and management’s outlook for future financial and operational performance. You can visit ir.priviahealth.com/news-and-events/events-and-presentations to listen to the call via live webcast. The webcast will be archived and available for replay for on-demand listening shortly after the completion of the call under the same link. Go to https://register-conf.media-server.com/register/BI4c0355cb60f4473db6a27e261c9996e2 in order to pre-register and obtain your dial-in number and passcode to join the live conference call.

This news release and the financial statements contained herein, and the slide presentation for the webcast, are also available on the Privia Health Investor Relations website at ir.priviahealth.com.

About Privia Health

Privia Health™ is one of the largest physician enablement companies in the United States with a presence in 25 states and the District of Columbia. Privia builds scaled provider networks with primary-care centric medical groups, risk-bearing entities, a physician-led governance structure, and the Privia Platform comprising an extensive suite of technology and service solutions. Privia collaborates with medical groups, health plans and health systems to optimize 1,300+ physician practices, improve the patient experience for 6.1+ million patients, and reward 5,600+ physicians and advanced practitioners for delivering high-value care.

Privia’s mission is to transform healthcare delivery to achieve better outcomes, lower costs, and improve the health of communities and the well-being of providers. For more information, visit priviahealth.com.

Non-GAAP Financial Measures

The Company reports and discusses its operating results using financial measures consistent with accounting principles generally accepted in the United States ("GAAP"). From time to time, in press releases, financial presentations, earnings conference calls or otherwise, the Company may disclose certain non-GAAP financial measures. The non-GAAP financial measures presented in this press release should not be viewed as alternatives or substitutes for the Company's reported GAAP results. A reconciliation to the most directly comparable GAAP financial measure is set forth in the tables that accompany this release.

The Company believes that the non-GAAP financial measures presented in this press release are relevant and provide useful information to the Company's management, investors, and other interested parties about the Company's operating performance because the measures allow them to understand and compare the Company's actual and expected operating results during the prior, current and future periods in a more consistent manner. The non-GAAP measures presented in this press release may not be comparable to similarly titled measures used by other companies. These non-GAAP financial measures are used in addition to and in conjunction with results presented in accordance with GAAP and reflect an additional way of viewing aspects of the Company's operations that, when viewed with GAAP results and the accompanying reconciliations to corresponding GAAP financial measures, provides a more complete understanding of the results of operations and trends affecting the³

Company's business. These non-GAAP financial measures should be considered as a supplement to, and not as a substitute for, or superior to financial measures calculated in accordance with GAAP.

Financial statements

Income Statement

Three Months Ended June 30, — Second Quarter Performance (unaudited; $ in millions, except per share amounts)

Three Months Ended June 30, – 2026Three Months Ended June 30, – 2025Change (%)*
Total revenue632.6521.221.4%
Gross profit128.9112.814.3%
Operating income11.83.3252.9%
Net income a92.7236.7%
Non-GAAP adjusted net income b25.321.318.7%
Net income per share0.070.02250.0%
Non-GAAP adjusted net income per share b0.190.1711.8%
*Any slight variations in totals are due to rounding. a.Net income for the three months ended June 30, 2026, included $19.4 million in non-cash stock compensation expense. Net income for the three months ended June 30, 2025 included $18.8 million in non-cash stock compensation expense. b.Reconciliations of non-GAAP adjusted net income and other non-GAAP financial measures are presented in tables near the end of this press release.*Any slight variations in totals are due to rounding. a.Net income for the three months ended June 30, 2026, included $19.4 million in non-cash stock compensation expense. Net income for the three months ended June 30, 2025 included $18.8 million in non-cash stock compensation expense. b.Reconciliations of non-GAAP adjusted net income and other non-GAAP financial measures are presented in tables near the end of this press release.*Any slight variations in totals are due to rounding. a.Net income for the three months ended June 30, 2026, included $19.4 million in non-cash stock compensation expense. Net income for the three months ended June 30, 2025 included $18.8 million in non-cash stock compensation expense. b.Reconciliations of non-GAAP adjusted net income and other non-GAAP financial measures are presented in tables near the end of this press release.

Income Statement

For the Six Months Ended June 30, — Six-Month Performance ($ in millions, except per share amounts)

For the Six Months Ended June 30, – 2026For the Six Months Ended June 30, – 2025Change (%)
Total revenue1,236.51,001.323.5%
Gross profit254.5216.417.6%
Operating income19.28.6124.4%
Net income a12.16.975.4%
Non-GAAP adjusted net income b d e49.641.220.4%
Net income per share0.090.0580.0%
Non-GAAP adjusted net income per share b d e0.380.3218.8%
a.Net income for the six months ended June 30, 2026 included $41.3 million in non-cash stock compensation expense. Net income for the six months ended June 30, 2025 included $36.6 million in non-cash stock compensation expense. b.Reconciliations of non-GAAP adjusted net income and other non-GAAP financial measures are presented in tables near the end of this press release.a.Net income for the six months ended June 30, 2026 included $41.3 million in non-cash stock compensation expense. Net income for the six months ended June 30, 2025 included $36.6 million in non-cash stock compensation expense. b.Reconciliations of non-GAAP adjusted net income and other non-GAAP financial measures are presented in tables near the end of this press release.a.Net income for the six months ended June 30, 2026 included $41.3 million in non-cash stock compensation expense. Net income for the six months ended June 30, 2025 included $36.6 million in non-cash stock compensation expense. b.Reconciliations of non-GAAP adjusted net income and other non-GAAP financial measures are presented in tables near the end of this press release.

Income Statement

For the Three Months Ended June 30, — (in thousands, except share and per share data)

For the Three Months Ended June 30, – 2026For the Three Months Ended June 30, – 2025For the Six Months Ended June 30, – 2026For the Six Months Ended June 30, – 2025
Revenue632,630521,1531,236,4771,001,250
Operating expenses:Provider expense500,484405,992975,601780,801
Operating expenses:Cost of platform69,35764,918137,777124,444
Operating expenses:Sales and marketing8,0026,80516,13613,727
Operating expenses:General and administrative39,65837,51981,13169,240
Operating expenses:Depreciation and amortization3,3562,5836,6374,484
Operating expenses:Total operating expenses620,857517,8171,217,282992,696
Operating expenses:Operating income11,7733,33619,1958,554
Operating expenses:Other income3,3103,310
Operating expenses:Interest income, net1,6682,4083,5565,339
Operating expenses:Income before provision for income taxes16,7515,74426,06113,893
Operating expenses:Provision for income taxes7,0172,45612,6174,559
Operating expenses:Net income9,7343,28813,4449,334
Operating expenses:Less: Net income attributable to non-controlling interests6866011,3322,427
Operating expenses:Net income attributable to Privia Health Group, Inc.9,0482,68712,1126,907
Operating expenses:Net income per share attributable to Privia Health Group, Inc. stockholders – basic0.070.020.10.06
Operating expenses:Net income per share attributable to Privia Health Group, Inc. stockholders – diluted0.070.020.090.05
Operating expenses:Weighted average common shares outstanding – basic126,121,426122,132,245125,142,415121,370,949
Operating expenses:Weighted average common shares outstanding – diluted131,827,233128,447,069131,355,421128,149,252

Income Statement

For the Three Months Ended June 30, — Revenues disaggregated by source: (in thousands)

For the Three Months Ended June 30, – 2026For the Three Months Ended June 30, – 2025For the Six Months Ended June 30, – 2026For the Six Months Ended June 30, – 2025
FFS-patient care412,640331,464803,773643,225
FFS-administrative services33,22235,11664,62567,371

Income Statement

For the Three Months Ended June 30, — (5)(k) (in thousands)

For the Three Months Ended June 30, – 2026For the Three Months Ended June 30, – 2025For the Six Months Ended June 30, – 2026For the Six Months Ended June 30, – 2025
Care Margin132,146115,161260,876220,449
Platform Contribution68,98957,466136,022109,199
Platform Contribution Margin52.2%49.9%52.1%49.5%
Adjusted EBITDA37,42928,99274,12055,907
Adjusted EBITDA Margin28.3%25.2%28.4%25.4%

Income Statement

For the Three Months Ended June 30, — (l) (in thousands)

For the Three Months Ended June 30, – 2026For the Three Months Ended June 30, – 2025For the Six Months Ended June 30, – 2026For the Six Months Ended June 30, – 2025
Revenue632,630521,1531,236,4771,001,250
Provider expense-500,484-405,992-975,601-780,801
Amortization of intangible assets-3,211-2,396-6,346-4,069
Gross Profit128,935112,765254,530216,380
Amortization of intangibles assets3,2112,3966,3464,069
Care Margin132,146115,161260,876220,449

Income Statement

For the Three Months Ended June 30, — (m) (in thousands)

For the Three Months Ended June 30, – 2026For the Three Months Ended June 30, – 2025For the Six Months Ended June 30, – 2026For the Six Months Ended June 30, – 2025
Revenue632,630521,1531,236,4771,001,250
Provider expense-500,484-405,992-975,601-780,801
Amortization of intangibles assets-3,211-2,396-6,346-4,069
Gross Profit128,935112,765254,530216,380
Amortization of intangibles assets3,2112,3966,3464,069
Cost of platform-69,357-64,918-137,777-124,444
Stock-based compensation(6)6,2007,22312,92313,194
Platform Contribution68,98957,466136,022109,199

Income Statement

For the Three Months Ended June 30, — (n) (in thousands)

For the Three Months Ended June 30, – 2026For the Three Months Ended June 30, – 2025For the Six Months Ended June 30, – 2026For the Six Months Ended June 30, – 2025
Net income9,0482,68712,1126,907
Net income attributable to non-controlling interests6866011,3322,427
Provision for income taxes7,0172,45612,6174,559
Interest income, net-1,668-2,408-3,556-5,339
Depreciation and amortization3,3562,5836,6374,484
Stock-based compensation19,39618,84941,31736,639
Other income-3,310-3,310
Other expenses(7)2,9044,2246,9716,230
Adjusted EBITDA37,42928,99274,12055,907

Balance Sheet

June 30, 2026 — (in thousands)

June 30, 2026 – (unaudited)December 31, 2025
Current assets:Cash and cash equivalents412,200479,685
Current assets:Accounts receivable574,160400,902
Current assets:Prepaid expenses and other current assets38,90630,414
Current assets:Total current assets1,025,266911,001
Non-current assets:Property and equipment, net272504
Non-current assets:Right-of-use assets8,0388,794
Non-current assets:Intangible assets, net218,654215,919
Non-current assets:Goodwill215,789209,842
Non-current assets:Deferred tax asset2,274
Non-current assets:Other non-current assets20,56221,044
Non-current assets:Total non-current assets463,315458,377
Non-current assets:Total assets1,488,5811,369,378
Current liabilities:Accounts payable and accrued expenses91,01096,804
Current liabilities:Provider liability541,368469,516
Current liabilities:Operating lease liabilities, current2,0662,200
Current liabilities:Total current liabilities634,444568,520
Non-current liabilities:Operating lease liabilities, non-current6,6677,331
Non-current liabilities:Deferred tax liability3,737
Non-current liabilities:Other non-current liabilities5,6602,584
Non-current liabilities:Total non-current liabilities16,0649,915
Non-current liabilities:Total liabilities650,508578,435
Stockholders’ equity:Common stock1,2631,236
Stockholders’ equity:Additional paid-in capital925,264892,291
Stockholders’ equity:Accumulated deficit-144,198-156,310
Stockholders’ equity:Total Privia Health Group, Inc. stockholders’ equity782,329737,217
Stockholders’ equity:Non-controlling interest55,74453,726
Stockholders’ equity:Total stockholders’ equity838,073790,943
Stockholders’ equity:Total liabilities and stockholders’ equity1,488,5811,369,378

Cash Flow

For the Six Months Ended June 30, — (in thousands)

For the Six Months Ended June 30, – 2026For the Six Months Ended June 30, – 2025
Cash flows from operating activitiesNet income13,4449,334
Adjustments to reconcile net income to net cash used in operating activities:Depreciation291415
Adjustments to reconcile net income to net cash used in operating activities:Amortization of intangibles6,3464,069
Adjustments to reconcile net income to net cash used in operating activities:Stock-based compensation41,31736,639
Adjustments to reconcile net income to net cash used in operating activities:Deferred income taxes, net3,6832,671
Changes in asset and liabilities:Accounts receivable, net-172,378-121,497
Changes in asset and liabilities:Prepaid expenses and other current assets-8,492-21,344
Changes in asset and liabilities:Other non-current assets and right-of-use assets1,4721,056
Full release

Safe Harbor Statement... (truncated)not final until the Company’s Form 10-Q is filed with the Securities and Exchange Commission (“SEC”). This press release contains "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such statements relate to our current expectations, projections and assumptions about our business, the economy and future events or conditions. They do not relate strictly to historical or current facts. Forward-looking statements can be identified by words such as “aims,” “anticipates,” "assumes," “believes,” “estimates,” “expects,” “forecasts,” “future,” “intends,” “likely,” “may,” “outlook,” “plans,” “potential,” “projects,” “seeks,” “strategy,” “targets,” “trends,” “will,” “would,” “could,” “should,” and variations of such terms and similar expressions and references to guidance, although some forward-looking statements may be expressed differently. In particular, these include statements relating to, among other things, our future actions, business plans, objectives and prospects; and our future operating or financial performance and projections, including our full year guidance for 2026. Factors or events that could cause actual results to differ may emerge from time to time and are difficult to predict. Should known or unknown risks or uncertainties materialize, or should underlying assumptions prove inaccurate, actual results may differ materially from past results and those anticipated, estimated or projected. We caution you not to place undue reliance upon any of these forward-looking statements.

Factors related to these risks and uncertainties include, but are not limited to: the heavily regulated industry in which we operate, and any failure by us or our medical groups to comply with the extensive applicable healthcare laws and government regulations; the complexity of the legal framework governing our relationships with Medical Groups, some of which we do not own, and Privia providers, and the impact of legal challenges or shifting interpretations of applicable laws; the execution of our growth strategy, which may not prove viable and we may not realize expected results; difficulties timely implementing our proprietary end-to-end, cloud-based technology solution for Privia physicians and new medical groups; the high level of competition in our industry; challenges in successfully establishing a presence in new geographic markets; the impact of failures by or service disruptions at key third-party vendors, such as our primary electronic medical record vendor, athenahealth, Inc.; potential decreases in reimbursement rates by governmental and third-party payers, changes to payment terms or challenges negotiating and retaining favorable contracts with private third-party payers, and changes impacting our patient population; the financial and operational impact of our compliance with various complex and changing federal and state privacy and security laws and regulations related to our use, disclosure, and other processing of personal information and protected health information, including the Health Insurance Portability and Accountability Act of 1996; the impact of actual and potential security threats, cybersecurity incidents or privacy or other forms of data breaches involving us, our vendors or other third parties; the continued availability of qualified workforce, including staff at our medical groups, and the continued upward pressure on compensation for such workforce; and other risk factors described in our Annual Report on Form 10-K for the year ended December 31, 2025 and the Company’s subsequent Quarterly Reports on Form 10-Q. All information in this press release is as of the date of the release, and the Company undertakes no duty to update this information unless required by law.⁴

Privia Health Group, Inc.

Condensed Consolidated Statements of Operations

(g)

(unaudited)

(in thousands, except share and per share data)

(g)

Any slight variations in totals due to rounding.⁵

Privia Health Group, Inc.

Condensed Consolidated Balance Sheets

(h)

(in thousands)

(h)

Any slight variations in totals are due to rounding.⁶

Privia Health Group, Inc.

Condensed Consolidated Statements of Cash Flows

(i)

(unaudited)

(in thousands)

(i)

Any slight variations in totals are due to rounding.⁷

Additional Financial Information

Revenues disaggregated by source:

The Company’s liabilities for unpaid medical claims under at-risk capitation arrangements:⁸

Key Metrics and Non-GAAP Financial Measures

Privia Health reviews a number of operating and financial metrics, including the following key metrics and non-GAAP financial measures, to evaluate the Company’s business, measure performance, identify trends affecting the Company’s business, formulate business plans, and make strategic decisions.

Key Metrics

(j)

Non-GAAP Financial Measures

(5)(k)⁹

Reconciliation of Gross Profit to Care Margin

(l)

Reconciliation of Gross Profit to Platform Contribution

(m)

Reconciliation of Net Income to Adjusted EBITDA

(n)¹⁰

Reconciliation of Net Income to Adjusted Net Income and Adjusted Net Income Per Share

(o)¹¹

Earlier releases

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.